IFirma Stock

IFirma ROCE

Return on Capital Employed (ROCE) of IFirma (IFI.WA) as of Jul 26, 2026.

ROCE

0.00

Last updated:

In 2026, IFirma's return on capital employed (ROCE) was 0.00, a % increase from the 70.14 % ROCE in the previous year.

Access this data via the Eulerpool API

IFirma Stock analysis

What does IFirma do? IFirma is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling IFirma's Return on Capital Employed (ROCE)

IFirma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing IFirma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

IFirma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in IFirma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about IFirma stock

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) IFirma since 2006 – with annual values, charts, and detailed analysis.

Access this data via the Eulerpool API

Profitability — IFirma

All Key Metrics — IFirma